San Francisco Sentry Investment Group’s Guardant Health GH Stock Holding History

San Francisco Sentry Investment Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$29K	Sell	233 -82	-26%	-$11K	0.02%	437
2021 Q1	$48K	Hold	315	–	–	0.02%	384
2020 Q4	$40K	Buy	315 +49	+18%	+$5.64K	0.02%	382
2020 Q3	$30K	Buy	266 +132	+99%	+$12.1K	0.02%	389
2020 Q2	$11K	Sell	134 -100	-43%	-$8.06K	0.01%	477
2020 Q1	$16K	Buy	234 +100	+75%	+$7.67K	0.01%	409
2019 Q4	$10K	Hold	134	–	–	﹤0.01%	560
2019 Q3	$9K	Sell	134 -3	-2%	-$264	﹤0.01%	567
2019 Q2	$12K	Buy	+137	New	+$10.5K	0.01%	531

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

San Francisco Sentry Investment Group's GH Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its Guardant Health (GH) stake by 26% in Q2 2021, selling an estimated $11K and leaving 233 shares worth $29K. The position accounts for 0.02% of the portfolio, ranked #437.

San Francisco Sentry Investment Group first reported a position in GH in Q2 2019 and has held it in 9 quarters since. The position peaked at $48K in Q1 2021. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

San Francisco Sentry Investment Group held 233 shares of Guardant Health worth $29K as of Q2 2021.
San Francisco Sentry Investment Group sold 82 Guardant Health shares in Q2 2021, an estimated $11K.
Guardant Health made up 0.02% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #437 holding.
San Francisco Sentry Investment Group first reported a position in Guardant Health in Q2 2019 and has held it in 9 quarters since.
San Francisco Sentry Investment Group's Guardant Health position peaked at $48K in Q1 2021.
417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.